These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer. Akins NS; Nielson TC; Le HV Curr Top Med Chem; 2018; 18(6):494-504. PubMed ID: 29788892 [TBL] [Abstract][Full Text] [Related]
4. The many faces of sirtuins: Sirtuins and the Warburg effect. Guarente L Nat Med; 2014 Jan; 20(1):24-5. PubMed ID: 24398961 [No Abstract] [Full Text] [Related]
5. [Proliferative ability of cell populations and treatment of neoplasms]. Rajewsky MF Nowotwory; 1976; 26(3):153-62. PubMed ID: 980800 [No Abstract] [Full Text] [Related]
6. Combination chemotherapy--theory and practice. Capizzi RL; Keiser LW; Sartorelli AC Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555 [No Abstract] [Full Text] [Related]
7. [Cancer cell kinetics and cancer multi-step therapy]. von Ardenne M Z Naturforsch B Anorg Chem Org Chem Biochem Biophys Biol; 1972 Dec; 27(12):1547-66. PubMed ID: 4143999 [No Abstract] [Full Text] [Related]
8. Continuing: Biology of cachexia. Bozzetti F J Natl Cancer Inst; 1999 Jun; 91(12):1077; author reply 1077-8. PubMed ID: 10379972 [No Abstract] [Full Text] [Related]
10. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment. Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276 [TBL] [Abstract][Full Text] [Related]
11. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect. Chen XS; Li LY; Guan YD; Yang JM; Cheng Y Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491 [TBL] [Abstract][Full Text] [Related]
13. Glutaminolysis and glycolysis interactions in proliferant cells. Medina MA; Núñez de Castro I Int J Biochem; 1990; 22(7):681-3. PubMed ID: 2205518 [No Abstract] [Full Text] [Related]
14. Cancer robustness: tumour tactics. Kitano H Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483 [No Abstract] [Full Text] [Related]
15. In vitro cytotoxic effect of some saccharide phenylhydrasone derivatives. Fuska J; Linek K; Buzinkay S Neoplasma; 1974; 21(5):561-8. PubMed ID: 4437682 [No Abstract] [Full Text] [Related]
16. Prostaglandins and the immune response to cancer (review). Ceuppens J; Goodwin J Anticancer Res; 1981; 1(2):71-8. PubMed ID: 6214207 [No Abstract] [Full Text] [Related]
17. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities. Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424 [TBL] [Abstract][Full Text] [Related]
18. Anthrax as a cancer drug? Dunn FB J Natl Cancer Inst; 2001 Nov; 93(22):1680-1. PubMed ID: 11717324 [No Abstract] [Full Text] [Related]
19. Antitumor agents and the molecular basis of cancer. Bloch AW Prog Clin Biol Res; 1985; 172B():207-13. PubMed ID: 3991709 [No Abstract] [Full Text] [Related]
20. [Cachexia in cancer: disturbances in the protein and aminoacid metabolism]. de Blaauw I; Deutz NE; von Meyenfeldt MF Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1408-13. PubMed ID: 10422554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]